Healogica
Healogica: An innovative platform for clinical trials matching, now part of Michael J. Fox Foundation.
Founded
2007Healogica: An innovative platform for clinical trials matching, now part of Michael J. Fox Foundation.
Healogica operated a Web-based clinical trials matching platform that helped patients find and apply to research studies suited to their condition. The service let users search trials by age, sex, ZIP code, and basic medical information, and its companion mobile app, Clinical Trials 2.0, brought the same search to iPhone users.
The platform served patients and their families alongside the research sponsors and study sites that struggled to recruit qualified participants. Healogica marketed the tool as a way to raise patient awareness of clinical research and speed trial enrolment, positioning itself between trial sponsors and prospective volunteers.
Recruitment remains one of the costliest and slowest parts of clinical research, and sponsors continue to test digital and remote methods for identifying eligible patients. The patient-recruitment problem Healogica addressed has since drawn investment into clinical trial technology and decentralized trial platforms.
Later entrants have benefited from broader smartphone adoption, electronic health record integration, and regulatory acceptance of remote trial participation, conditions that were immature when Healogica operated. The company's early experience illustrates both the scale of the recruitment problem and the commercial patience it demands.
Healogica was among the first services to combine clinical trial search with a mobile application, launching its 99-cent Clinical Trials 2.0 app in 2009 when most trial directories were desktop-only. The price undercut rival apps such as StopWatch Media's Clinical Trials, which then sold for 9.99 dollars.
The platform's consumer-first design let patients and caregivers search by personal criteria rather than clinical terminology, and the company paired the tool with an educational blog about medical research. Its founders' clinical backgrounds gave it credibility with both patient communities and research sponsors.
Healogica depended on patient willingness to share personal health information online, and qualified volunteers proved reluctant to enrol through a Web tool. The hesitancy limited the number of matched participants and undercut the value the company could offer trial sponsors.
When Healogica turned to pharmaceutical companies for revenue, it encountered long procurement cycles and cautious legal review that slowed adoption of mobile recruitment. Competitors with deeper ties to trial sites and health systems, and with paid rather than consumer channels, were better positioned to weather that friction.